CLINICAL PHARMACOLOGY CONSULTATION AND OUTCOMES ASSOCIATED WITH PREGNANCY EXPOSURE TO FDA CATEGORY X DRUGS

被引：0
|
作者：
Turk, Erdeljic, V
Francetic, I
Ksenija, M.
Matea, R.
Robert, L.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2014年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
200
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] CLINICAL PHARMACOLOGY CONSULTATION AND OUTCOMES ASSOCIATED WITH PREGNANCY EXPOSURE TO FDA X DRUGS
    Turk, V. Erdeljic
    Francetic, I.
    Auspergeri, K. Makar
    Likic, R.
    Radacic-Aumiler, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E14 - E15
  • [2] Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population
    Yang, Tubao
    Walker, Mark C.
    Krewski, Daniel
    Yang, Qiuying
    Nimrod, Carl
    Garner, Peter
    Fraser, William
    Olatunbosun, Olufemi
    Wen, Shi Wu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (03) : 270 - 277
  • [3] Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs
    Yang Jianzhou
    Xie Rihua
    Krewski, Daniel
    Wang Yongjin
    Walker, Mark
    Cao Wenjun
    Wen, Shi Wu
    CHINESE MEDICAL JOURNAL, 2014, 127 (04) : 702 - 706
  • [4] Adverse Pregnancy Outcomes Associated With Gestational Exposure to Antiepileptic Drugs
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2018, 79 (04)
  • [5] Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population
    S W Wen
    T Yang
    D Krewski
    Q Yang
    C Nimrod
    P Garner
    W Fraser
    O Olatunbosun
    M C Walker
    Journal of Perinatology, 2008, 28 : 324 - 329
  • [6] Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population
    Wen, S. W.
    Yang, T.
    Krewski, D.
    Yang, Q.
    Nimrod, C.
    Garner, P.
    Fraser, W.
    Olatunbosun, O.
    Walker, M. C.
    JOURNAL OF PERINATOLOGY, 2008, 28 (05) : 324 - 329
  • [7] Outcomes of pregnancy after exposure to antiglaucoma drugs
    Shakha
    Gupta, Shikha
    Panigrahi, Arnav
    Singh, Abhishek
    Gupta, Viney
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (04) : 599 - 601
  • [8] Birth outcomes after inadvertent use of category X drugs contraindicated in pregnancy: Where is the real risk?
    Ozturk, Zeynep
    Olmez, Ercument
    Gurpinar, Tugba
    Vural, Kamil
    TURKISH JOURNAL OF PEDIATRICS, 2018, 60 (03) : 298 - 305
  • [9] OUTCOMES OF PREGNANCY-ASSOCIATED WITH ANTIEPILEPTIC DRUGS
    WATERS, CH
    BELAI, Y
    GOTT, PS
    SHEN, P
    DEGIORGIO, CM
    ARCHIVES OF NEUROLOGY, 1994, 51 (03) : 250 - 253
  • [10] Obstetric outcomes associated with increase in BMI category during pregnancy
    Kabiru, W
    Raynor, BD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (03) : 928 - 932
12345